Evolution and Milestone

Back to Home

Evolution and Milestone

  • 2021
    CEP for Pentoxifylline and Esketamine Hydrochloride.
    NMPA Approval.
    Health Canada Approval
  • 2020
    Third time USFDA Approval
  • 2018
    CEP for Brompheniramine Maleate, Mepyramine Maleate & Ketamine Hydrochloride
  • 2017
    CEP for Pheniramine Maleate, Second time USFDA Approval
  • 2015
    EUGMP and EDQM Approval
  • 2014
    USFDA Approval.
    IDL for Brompheniramine Maleate
  • 2013
    COFEPRIS and KFDA Approval
  • 2011
    IDL for Chlorpheniramine Maleate
  • 2010
    CEP for Chlorpheniramine Maleate
  • 2008
    Incorporation & conversion from a partnership firm to a public limited company
  • 2007
    National Award for Best Entrepreneur
  • 2006
    Became the Second Largest Manufacturer of Vitamin B2 5 Phosphate Sodium
  • 2004
    Became the Largest Manufacturer of Chlorpheniramine Maleate
  • 2003
    National Award for Quality
  • 2001
    National Award for
    Excellence in R&D
  • 2000
    Conferred the status of "Export House" by the Government of India.
  • 1993
    Started Manufacturing APIs
  • 1987
    Incorporation as Supriya Chemicals - A Partnership Firm